The Patent Finder

Exonhit Therapeutics S.A.

Also on record
Records under this name other than the patents Exonhit Therapeutics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.

Back to Exonhit Therapeutics S.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,168,6313-(4-Fluorophenyl)-3-Hydroxy-2-Amino-PROPIONIC Acid Amides and Related Compounds Having Analgesic Activity
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,479,826Method and System for Wireless Data Communication
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,902,710Substituted 6, 7-Dialkoxy-3-Isoquinoline Derivatives as Inhibitors of Phosphodiesterase 10 (PDE 10A)
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,835,463Compounds Having Analgesic And/Or Immunostimulant Activity
Term ended
Term ended Sep 8, 2026 · High confidence
Term endedTerm ended Sep 8, 2026High confidence
US 8,772,316Substituted 6,7-Dialkoxy-3-Isoquinolinol Derivatives as Inhibitors of Phosphodiesterase 10 (PDE10A)
Lapsed on the fee record
Ended Jul 8, 2026 · High confidence
Lapsed on the fee recordEnded Jul 8, 2026High confidence
US 8,431,5993-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
Term ended
Term ended Jan 25, 2026 · USPTO record
Term endedTerm ended Jan 25, 2026USPTO record
US 8,927,5893-ARYL-3-Hydroxy-2-Amino-PROPIONIC Acid Amides, 3-Heteroaryl-3-Hydroxy-2-Aminopropionic Acid Amides and Related Compounds Having Analgesic And/Or Immuno Stimulant Activity
Term ended
Term ended Jan 25, 2026 · Medium confidence
Term endedTerm ended Jan 25, 2026Medium confidence
US 9,278,943Methods of Using as Analgesics 1-Benzyl-1-Hydroxy-2, 3-Diamino-PROPYL Amines, 3-Benzyl-3-Hydroxy-2-Amino-PROPIONIC Acid Amides and Related Compounds
Term ended
Term ended Jan 25, 2026 · High confidence
Term endedTerm ended Jan 25, 2026High confidence
US 9,828,3491-ARYL-1-Hydroxy-2,3-Diamino-PROPYL Amines, 1-Heteroaryl-1-Hydroxy-2,3-Diamino-PROPYL Amines and Related Compounds Having Analgesic And/Or Immuno Stimulant Activity
Term ended
Term ended Jan 25, 2026 · High confidence
Term endedTerm ended Jan 25, 2026High confidence
US 8,513,2881-ARYL-1-Hydroxy-2,3-Diamino-PROPYL Amines, 1-Heteroaryl-1-Hydroxy-2,3-Diamino-PROPYL Amines and Related Compounds Having Analgesic And/Or Immuno Stimulant Activity
Lapsed on the fee record
Ended Aug 20, 2025 · High confidence
Lapsed on the fee recordEnded Aug 20, 2025High confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited